drugset / Trial / NCT03377257
Efficacy and Safety of Zolmitriptan by Sublingual Administration
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose is to evaluate the effectiveness and safety profile of zolmitriptan by Sublingual administration for the acute treatment of Cluster headache.
Timeline
- Start
- 2018-01-01
- Primary completion
- 2018-12-31
- Completion
- 2019-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zolmitriptan | Small molecule | 2.5 mg | Other |